Cargando…

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis

Systemic sclerosis is a connective tissue disease of unknown origin and with an unpredictable course, with both cutaneous and internal organ manifestations. Despite the enormous progress in rheumatology and clinical immunology, the background of this disease is largely unknown, and no specific thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gumkowska-Sroka, Olga, Kotyla, Kacper, Mojs, Ewa, Palka, Klaudia, Kotyla, Przemysław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458905/ https://www.ncbi.nlm.nih.gov/pubmed/37630981 http://dx.doi.org/10.3390/ph16081066

Ejemplares similares

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2022)

Adhesion molecules: a way to understand lupus
por: Nowak, Karolina, et al.
Publicado: (2022)

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2019)

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2023)

Psychological Implications to the Therapy of Systemic Lupus Erythematosus
por: Warchoł-Biedermann, Katarzyna, et al.
Publicado: (2022)

Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis
por: Kotyla, Przemyslaw J.
Publicado: (2018)

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
por: Kotyla, Przemyslaw J.
Publicado: (2018)

Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature
por: Luboń, Wojciech, et al.
Publicado: (2022)

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
por: Kotyla, Przemyslaw J.
Publicado: (2018)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
por: Kotyla, Przemysław J., et al.
Publicado: (2020)

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)
por: Kotyla, Przemysław J., et al.
Publicado: (2020)

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
por: Gieszczyk-Strózik, Klaudia, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker
por: Kotyla, Przemyslaw J., et al.
Publicado: (2018)

Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury
por: Kuźnik-Trocha, Kornelia, et al.
Publicado: (2022)

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
por: Islam, Md Asiful, et al.
Publicado: (2020)

Dercum’s disease (adiposis dolorosa): a review of clinical presentation and management
por: Kucharz, Eugeniusz J., et al.
Publicado: (2019)

Mixed generalized/juxta-articular form of Dercum’s disease
por: Kucharz, Eugeniusz J., et al.
Publicado: (2016)

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
por: Kotyla, Przemysław J., et al.
Publicado: (2021)

Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta
por: Kuźnik-Trocha, Kornelia, et al.
Publicado: (2020)

Editorial: Autoimmunity and cardiovascular diseases
por: Khandker, Shahad Saif, et al.
Publicado: (2023)

The Prevalence of Anticitrullinated Protein Antibodies in Older Poles—Results from a Population-Based PolSenior Study
por: Chudek, Anna, et al.
Publicado: (2022)

Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient
por: Mojs, Ewa, et al.
Publicado: (2018)

Old and new therapeutic strategies in systemic sclerosis (Review)
por: Bobeica, Carmen, et al.
Publicado: (2022)

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
por: Benfaremo, Devis, et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012)

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis
por: Islam, Md Asiful, et al.
Publicado: (2020)

Therapeutic targets in systemic sclerosis
por: Denton, Christopher P
Publicado: (2007)

Cell-based therapeutic strategies for multiple sclerosis
por: Scolding, Neil J, et al.
Publicado: (2017)

New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
por: Zielińska-Nowak, Ewa, et al.
Publicado: (2020)

Novel Insights and Therapeutics in Multiple Sclerosis
por: Wagner, Catriona A., et al.
Publicado: (2015)

New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics
por: Ebata, Satoshi, et al.
Publicado: (2022)

Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis
por: Sever, Belgin, et al.
Publicado: (2022)

Disturbances of the stomatognathic system and possibilities of its correction in patients with craniofacial morphea
por: Wróblewska, Agnieszka, et al.
Publicado: (2023)

Novel Drugs in a Pipeline for Progressive Multiple Sclerosis
por: Sapko, Klaudia, et al.
Publicado: (2022)

The scientific basis for novel treatments of systemic sclerosis
por: Beyer, Christian, et al.
Publicado: (2009)

Novel Therapeutic Strategies in the Topical Treatment of Atopic Dermatitis
por: Pinto, Lorenzo Maria, et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
por: Yang, Xiaoming, et al.
Publicado: (2021)

The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
por: Veauthier, Christian, et al.
Publicado: (2016)

Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders
por: Yavarpour-Bali, Hanie, et al.
Publicado: (2019)

Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis
por: Harris, Edward S, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mdafdrcinog1rglurq941md2oj